3
$C3is(CISS.US$ Breakout soon
1
$C3is(CISS.US$ Market cap: 2.2m
Q4 Revenue: 13.8m (+37% from Q3)
Q4 Income: 5.6m (+70% from Q3)
Q4 Assets: 90.8m
Q4 Liabilities: 40.5m
Cash: 35.6m (as of March 26th)
Q4 Revenue: 13.8m (+37% from Q3)
Q4 Income: 5.6m (+70% from Q3)
Q4 Assets: 90.8m
Q4 Liabilities: 40.5m
Cash: 35.6m (as of March 26th)
4
2
$C3is(CISS.US$ Valuation is dirt cheap here
2
1
$Upwork(UPWK.US$ Given low valuation and post earning upgrades and price targets of 18 and 20 no reason for this not to break above 15 (top od triangle)
$Longeveron(LGVN.US$ Anyone saw this video? ceo says looking to partner with large pharma for phase 3
youtu.be/a3J81p...
youtu.be/a3J81p...
1
$Fisker(FSR.US$ Floor price of notes is 1.16. No other explanation. Company just paid off debt. No more inventory for shortable sharss now and cost to borrow skyrocketing. It all adds up. Buy
6
1